Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

GILD Hep C Drugs Will Likely Be Approved In China In 2017 - According To An Unnamed China FDA Source

|Includes: BMY, Gilead Sciences, Inc. (GILD)

Upon approval of the first Hep C drug from BMY last week, a news report said: "Better news are coming. We plan to approve 7 drugs this year, to cover all genotypes of Hep C - according to a source from China FDA."

The report is from one of the most reputable news organizations in China "Southern Weekly". The link to the report is here (use Google translate if you can't read Chinese): www.infzm.com/content/124415

There are more than 10 million hep C infections in China.

Disclosure: I am/we are long GILD.